Jump to content

IHI call 3

Funding programme
Submission deadline:
Funded by:
European Union
Germany and Europe

The following text does not reflect the entire content of the announcement, but contains individual extracts from the guideline.

The Innovative Health Initiative Joint Undertaking (IHI JU) is a partnership between the European Union and industry associations representing the sectors involved in healthcare, namely COCIR (medical imaging, radiotherapy, health ICT and electromedical industries); EFPIA, including Vaccines Europe (pharmaceutical industry and vaccine industry); EuropaBio (biotechnology industry); and MedTech Europe (medical technology industry).

IHI JU aims to pioneer a new, more integrated approach to health research and builds on the experience gained from the Innovative Medicine Initiative 2 Joint Undertaking (IMI2 JU).

IHI JU aims to translate health research and innovation into real benefits for patients and society, and ensure that Europe remains at the cutting edge of interdisciplinary, sustainable, patient-centric health research. Health research and care increasingly involve diverse sectors. By supporting projects that bring these sectors together, IHI JU will pave the way for a more integrated approach to health care, covering prevention, diagnosis, treatment, and disease management.

IHI call 3 is a single-stage call with topics on diseases of unmet public health need, rare diseases, mental health, hospital efficiencies, and patient-generated evidence.

Call ID: HORIZON-JU-IHI-2022-03-single-stage
Action Type: RIA – Research and Innovation Actions
Call type: Single stage


  • Topic 1: Screening platform and biomarkers for prediction and prevention of diseases of unmet public health need

  • Topic 2: Patient-generated evidence to improve outcomes, support decision making, and accelerate innovation

  • Topic 3: Combining hospital interventional approaches to improve patient outcomes and increase hospital efficiency

  • Topic 4: Strengthening the European translational research ecosystem for advanced therapy medicinal products (ATMPs) for rare diseases

  • Topic 5: Digital health technologies for the prevention and personalised management of mental disorders and their long-term health consequences

Indicative budget

  • The maximum financial contribution from IHI JU for these topics is: EUR 138 million
  • Industry / contributing partner contributions: Applicant consortia should ensure that out of the total project budget, at least 45 % needs to be covered by contributions provided by project participants

How to apply

All documents relating to the call can be found via the Funding and Tenders Portal and the IHI call documents page. We advise you to read these documents, in particularly the guide for applicants, carefully.

Proposals must be submitted via the electronic submission system of the Funding and Tenders Portal. To start submitting your proposal, simply click on the relevant topic above - this will take you directly to that topic's page on the portal. Once there, scroll down and click on 'Start submission'.

To submit a proposal via the electronic submission system, you will need to have an EU Login account and ensure that your organisation is registered as a beneficiary.

Website address: https://www.bio-pro.de/en/service/funding/ihi-call-3